Vnitr Lek 2007, 53(10):1024-1028

Endoskopické změny sliznice ľaludku a dvanáctníku při léčbě minidávkou acetylsalicylové kyseliny a jejich prevence - editorial

J. Ehrmann1,*, V. Procházka1, M. Konečný2, M. ©paček2, K. Urbánek3
1 II. interní klinika Lékařské fakulty UP a FN Olomouc, přednosta doc. MUDr. Vlastimil Procházka, Ph.D.
2 Interní oddělení nemocnice Prostějov, přednosta prim. MUDr. Bohuslav Černoąek
3 Ústav farmakologie Lékařské fakulty UP Olomouc, přednosta prof. MUDr. Pavel Anzenbacher, DrSc.

Received: June 15, 2007; Published: October 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ehrmann J, Procházka V, Konečný M, ©paček M, Urbánek K. Endoskopické změny sliznice ľaludku a dvanáctníku při léčbě minidávkou acetylsalicylové kyseliny a jejich prevence - editorial. Vnitr Lek. 2007;53(10):1024-1028.
Download citation

References

  1. Bonnet J. Review article: a cardiologist's view of the risks and benefit of cyclo-oxygenase-2 inhibitors, aspirin and other non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther Symp Ser 2005; 1: 11-15. Go to original source...
  2. Cole AT, Hudson N, Liew LCW et al. Protection of human gastric mucosa against aspirin enteric-coating or dose reduction. Aliment Pharmacol Ther 1999; 13: 187-193. Go to original source... Go to PubMed...
  3. Dammann HG, Burkhardt F, Wolf N. Enteric-coating aspirin significantly decreases gastroduodenal mucosal lesions. Aliment Pharmacol Ther 1999; 13: 1109-1114. Go to original source... Go to PubMed...
  4. Dítě P, Novotný I, Kunovská M et al. Minidávka kyseliny acetylsalicylové (ASA) a endoskopické změny sliznice ľaludku a dvanáctníku. Čes Slov Gastroent Hepatol 2006, 60: 213-214.
  5. Ens G, Guyer KE. Monitoring aspirin therapy: a question of resistance or treatment failure? CLI 2007; 31: 26-27.
  6. Kelly JP, Kaufman DW, Jurgelon JM et al. Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. Lancet 1996; 348: 1413-1416. Go to original source... Go to PubMed...
  7. Konečný M, Ehrmann J. Krvácení do trávícího ústrojí. Postgrad Med 2004; 6: 610-615.
  8. Konečný M, Ehrmann J, Procházka V. Efficiency of endoscopic treatment of acute non-variceal upper GI bleeding with condicions of the centralized integrated care. BMJ 2005; 54(Suppl 1): A 269.
  9. Konečný M, Procházka V. Advancement in etiology of gastroduodenal peptic ulcer with active bleeding. Gut 2006; 55(Suppl 5): A211.
  10. Laine L Review article: gastrointestinal bleeding with low-dose aspirin-what's the risk? Aliment Pharmacol Ther 2006; 24: 897-908. Go to original source... Go to PubMed...
  11. Laine L, Bombardier C, Hawkey CJ et al. Stratifying the risk of NSAIDs-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis. Gastroenterology 2002; 123: 1006-1012. Go to original source... Go to PubMed...
  12. Laine L, Maller ES, Yu C et al. Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial. Gastroenterology 2004; 127: 395-402. Go to original source... Go to PubMed...
  13. Lanza FL, Royer GL, Nelson RS. Endoscopic evaluation of the effects of aspirin, bufferd aspirin, and enteric coated aspirin on gastric and duodenal mucosa. N Engl J Med 1980; 303: 136-138. Go to original source... Go to PubMed...
  14. Mařatka Z. Endoskopická diagnostika a terminologie erozí a podobných slizničních lézí. Čes Slov Gastroent Hepatol 1995, 49: 96-98.
  15. Mařatka Z et al. Terminology, definitions and diagnostic criteria in digestive endoscopy. Bad Homburg: Normed 1993.
  16. McQuaid KR, Laine L. Systemic review and meta-analysis of adverse evenst of low-dose aspirin and clopidogrel in randomized controlled trialis. Am J Med 2006; 119: 624-638. Go to original source... Go to PubMed...
  17. Micklewright R, Lane S, Linley W et al. Review article: NSAIDs, gastroprotection and cyclo-oxygenase-II-selective inhibitors. Aliment Pharmacol Ther 2003; 17: 321-332. Go to original source... Go to PubMed...
  18. Niv Y, Battler A, Abuksis G et al. Endoscopy in asymptomatic minidose aspirin consumers. Dig Dis Sci 2005; 50: 78-80. Go to original source... Go to PubMed...
  19. Penka M. Kyselina acetylsalicylová - je nám vąe jasné? Spíąe není. Vnitř Lék 2002; 48: 698-700. Go to PubMed...
  20. Rodriguez LAG, Hernández-Diaz S, de Abájo FJ. Association between aspirin and upper gastrointestinal complications: Systemic review of epidemiologic studies. Br J Clin Pharmacol 2001; 52: 563-571 Go to original source... Go to PubMed...
  21. Serrano P, Lanas A, Arroyo MT et al. Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for prevention of cardiovascular disease. Aliment Pharmacol Ther 2002; 16: 1945-1963. Go to original source... Go to PubMed...
  22. Silverstein FE, Graha DY, Senior JR. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995; 123: 241-249. Go to original source... Go to PubMed...
  23. ©ejfa M et al. Kardiologie. 3. ed. Praha: Grada 2007; 314-316.
  24. Vítovec J, ©pinar J et al. Farmakoterapie kardiovaskulárních onemocnění. 2. ed. Praha: Grada Publishing 2004: 126-129.
  25. Weaver AL Review article: aspirin, non-steroidal anti-inflammatory drugs and cyclo-oxygenase-1 sparing agents. Aliment Pharmacol Ther Symp Ser 2005; 1: 2-5. Go to original source...
  26. Weil J, Colin-Lones D, Langman M et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995; 310: 815-816. Go to original source... Go to PubMed...
  27. Novotný I, Dítě P, Kunovská H et al. Endoskopické změny sliznice ľaludku a dvanáctníku při léčbě minidávkou acetylsalicylové kyseliny a jejich prevence. Vnitř Lék 2007; 53(10): 1053-1056. Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.